English | Español
Patient Daily | Apr 10, 2026

Sotatercept shows improvement for patients with CpcPH-HFpEF in phase 2 trial
Patient Daily | Apr 10, 2026

Noninvasive lung monitoring device reduces hospitalizations and deaths in HFpEF patients
Patient Daily | Apr 10, 2026

Eli Lilly announces expanded partnership with Insilico Medicine in AI drug development deal
Patient Daily | Apr 10, 2026

Biogen’s lupus drug shows reduced disease activity in mid-stage trial results
Patient Daily | Apr 10, 2026

Merck advances Winrevair to pivotal study after mid-stage heart failure trial results
Patient Daily | Apr 10, 2026

FDA approves high-dose Spinraza for spinal muscular atrophy treatment
Patient Daily | Apr 10, 2026

AbbVie maintains confidence in Skyrizi after FDA approval of Icotyde for plaque psoriasis
Patient Daily | Apr 10, 2026

Takeda restructuring could affect more than 600 US employees, company says

Trending
Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families
+ Marketing
A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’
+ Regulatory
Patient Daily News Service | Jun 9, 2026

New colon cancer blood test wins Medicare coverage, but trails stool-based screening in detecting precancerous lesions
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

FDA rare disease framework faces uncertainty after leadership departures